ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Lab4Paws Logo

Use Case

Plasma from Cat with Mammary Cancer for Diagnostics & Biomarker Development

Image
image-0

Use Case

Plasma from Cat with Mammary Cancer for Diagnostics & Biomarker Development

Description

This study investigated the potential of microRNAs (miRNAs) in extracellular vesicles (EVs) from feline plasma as biomarkers for feline mammary adenocarcinomas (FMAs). The researchers analyzed miRNA expression in tumor tissue, tumor-free margins, and plasma-derived EVs from felines with FMA. RT-qPCR analyses revealed significantly increased miR-20a and miR-15b in tumors compared to margins, while a significant decrease in miR-15b and miR-20a was detected in EVs from FMAs compared to healthy feline EVs. Proteomic analysis of EVs distinguished FMAs from controls, with lower levels of protein targets of miR-20a and miR-15b in EVs from patients with FMA. The study demonstrated that miRNAs are detectable in both tissue and plasma-derived EVs from FMA patients and could potentially be used as a panel of markers in circulating plasma EVs for non-invasive diagnostic tests. [Ref: Howard, J., Browne, J., Bollard, S. et al. The protein and miRNA profile of plasma extracellular vesicles (EVs) can distinguish feline mammary adenocarcinoma patients from healthy feline controls. Sci Rep 13, 9178 (2023). https://doi.org/10.1038/s41598-023-36110-7]

Details

Industries:

Cancer Research, Biomarker Development

Related product to Plasma from Cat with Mammary Cancer for Diagnostics & Biomarker Development

Plasma from Cat with Mammary Cancer for Diagnostics & Biomarker Development is a Use Case of:

Product: Feline Plasma - Mammary Carcinoma

Product

Feline Plasma - Mammary Carcinoma

Go to product

Your contact person

Interested in this use case? An employee of Lab4Paws is at your disposal.

Contact person image

Davide Confalonieri, PhD

CEO

More Use Cases of Lab4Paws

Get insights into the use cases of Lab4Paws

UseCase: Animal PBMCs for Antibody Discovery

Use Case

Animal PBMCs for Antibody Discovery

Antibody Production

PBMCs are used in antibody discovery due to their role in the immune response. Antibody-secreting cells (ASCs), a type of PBMC, are an excellent source of high-affinity antibodies with therapeutic potential. Millions of PBMCs can be isolated and screened to identify antigen-specific ASCs that secrete antibodies with desirable properties. One method involves microfluidic encapsulation of single ASCs into an antibody capture hydrogel, followed by antigen bait sorting using flow cytometry, enabling the rapid discovery of monoclonal antibodies. These antibodies can then be further characterized for their binding affinity and neutralizing capacity, making PBMCs a valuable resource for developing antibody-based drugs and studying immune responses. [Ref: Fischer, K., Lulla, A., So, T.Y. et al. Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells. Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02346-5]

UseCase: Beagle PBMCs for Antibody Discovery

Use Case

Beagle PBMCs for Antibody Discovery

antibody production

Beagle PBMCs have been used to generate anti-canine CD20 antibodies, which can target B cells and B cell lymphoma cells. These antibodies are tested for their binding affinity and ability to induce cell death, showing promise as therapeutic antibodies for treating canine B cell lymphoma. [Ref: Mizuno, T., Kato, Y., Kaneko, M.K. et al. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Sci Rep 10, 11476 (2020). https://doi.org/10.1038/s41598-020-68470-9]

UseCase: Pig/Minipig PBMCs for Antibody Discovery

Use Case

Pig/Minipig PBMCs for Antibody Discovery

Antibody Production

Pig PBMCs have been used in antibody discovery to isolate antigen-specific B cells for monoclonal antibody (mAb) cloning. For example, researchers have established platforms to sort antigen-specific single B cells from immunized pigs, allowing for the direct cloning and expression of antigen-specific mAbs. Sequential vaccination of pigs with different serotypes of the foot-and-mouth disease virus (FMDV) enabled the isolation of broadly neutralizing antibodies (bnAbs) by dissecting B-cell receptor (BCR) gene repertoires from PBMCs. [Ref: Li, F., Wu, S., Lv, L., Huang, S., Zhang, Z., Zerang, Z., Li, P., Cao, Y., Bao, H., Sun, P., Bai, X., He, Y., Fu, Y., Yuan, H., Ma, X., Zhao, Z., Zhang, J., Wang, J., Wang, T., Li, D., … Li, K. (2024). Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus. PLoS pathogens, 20(10), e1012623. https://doi.org/10.1371/journal.ppat.1012623]

More Products & Services of Lab4Paws.

Lab4Paws offers a wide range of products and services.

Product: Animal PBMCs

Product

Animal PBMCs

Go to product

Product: Beagle PBMCs

Product

Beagle PBMCs

Go to product

Product: Pig/Minipig PBMCs

Product

Pig/Minipig PBMCs

Go to product

Product: Cynomolgus PBMCs

Product

Cynomolgus PBMCs

Go to product

Product: Llama PBMCs

Product

Llama PBMCs

Go to product

Product: Alpaca PBMCs

Product

Alpaca PBMCs

Go to product